Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Notice on Health Canada’s proposed changes to the guidance on recognized standards...

Health Canada has updated the: List of recognized standards for medical devices and Guidance on using standards to support compliance with the Medical Device Regulations The...

USA – FDA unveils FY 2025 user fee rates

The US Food and Drug Administration (FDA) has published its user fee rates for fiscal year 2025 across its prescription drug, generic drug, biosimilar,...
Coronavirus delays many FDA foreign inspections

USA – FDA finalizes COVID-era guidance on container closure changes

The US Food and Drug Administration (FDA) has finalized a guidance to assist sponsors in reporting common changes made to glass vials and stoppers,...

Canada – Notice on Health Canada’s proposed changes to the guidance on recognized standards...

About the updates Health Canada has updated the: List of recognized standards for medical devices and Guidance on using standards to support compliance with the Medical...

USA – FDA issues final guidance user fees for combination products

The US Food and Drug Administration (FDA) on Tuesday finalized guidance for sponsors explaining how it assesses user fees for combination products and the...

USA – Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder

The opioid epidemic is a serious and complex public health emergency facing the United States. The Agency has already taken significant steps to decrease...

USA – FDA releases draft guidance on use-related risk analysis for combo products

The US Food and Drug Administration (FDA) has released a draft guidance outlining the purpose and content of a use-related risk analysis (URRA) for...

USA – FDA drafts guidance on essential outputs for drug delivery devices

The US Food and Drug Administration (FDA) has issued a draft guidance to assist sponsors of drug-device combination products in developing “essential drug delivery...

USA – Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological...

This guidance addresses key aspects of drug delivery performance information for devices, and combination products that include device constituent parts, intended for delivery of...

USA – FDA concerned about potential device shortages due to new EtO limits

Rural and vulnerable populations could be placed at risk as the US Environmental Protection Agency (EPA) imposes new limits on the use of ethylene...

NOS PROCHAINES FORMATIONS